Arrow Mark Colorado Holdings LLC Arvinas, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$7.03 Billion
Q3 2024

A detailed history of Arrow Mark Colorado Holdings LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Arrow Mark Colorado Holdings LLC holds 1,244,450 shares of ARVN stock, worth $22.3 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares

1,244,450

Previous 1,226,727 1.44%

Holding current value

$22.3 Million

Previous $32.7 Million 6.14%

% of portfolio

0.44%

Previous 0.43%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$23.66 - $32.73 $419,326 - $580,073	17,723 Added 1.44%	1,244,450 $30.7 Million
Q2 2024 Aug 14, 2024	BUY	$24.46 - $40.4 $517,549 - $854,823	21,159 Added 1.76%	1,226,727 $32.7 Million
Q1 2024 May 15, 2024	SELL	$36.38 - $52.31 $13.3 Million - $19.1 Million	-364,327 Reduced 23.21%	1,205,568 $49.8 Million
Q4 2023 Feb 14, 2024	SELL	$14.19 - $42.33 $3.3 Million - $9.84 Million	-232,389 Reduced 12.89%	1,569,895 $64.6 Million
Q2 2023 Aug 14, 2023	BUY	$21.73 - $31.43 $5.06 Million - $7.32 Million	232,886 Added 14.84%	1,802,284 $44.7 Million
Q1 2023 May 15, 2023	BUY	$26.15 - $37.26 $9.77 Million - $13.9 Million	373,739 Added 31.26%	1,569,398 $42.9 Million
Q4 2022 Feb 14, 2023	BUY	$32.47 - $57.24 $7.85 Million - $13.8 Million	241,783 Added 25.35%	1,195,659 $40.9 Million
Q3 2022 Nov 14, 2022	SELL	$41.87 - $57.99 $3.9 Million - $5.4 Million	-93,073 Reduced 8.89%	953,876 $42.4 Million
Q2 2022 Aug 15, 2022	BUY	$36.01 - $74.24 $11.5 Million - $23.7 Million	319,223 Added 43.87%	1,046,949 $44.1 Million
Q1 2022 May 16, 2022	BUY	$60.27 - $81.57 $2.05 Million - $2.78 Million	34,030 Added 4.91%	727,726 $49 Million
Q4 2021 Feb 14, 2022	BUY	$65.85 - $96.21 $16.3 Million - $23.9 Million	247,971 Added 55.63%	693,696 $57 Million
Q3 2021 Nov 15, 2021	SELL	$73.2 - $107.87 $1.22 Million - $1.8 Million	-16,726 Reduced 3.62%	445,725 $36.6 Million
Q2 2021 Aug 16, 2021	SELL	$60.45 - $84.26 $5.86 Million - $8.16 Million	-96,894 Reduced 17.32%	462,451 $35.6 Million
Q1 2021 May 17, 2021	SELL	$58.19 - $91.37 $1.01 Million - $1.58 Million	-17,272 Reduced 3.0%	559,345 $37 Million
Q4 2020 Feb 16, 2021	BUY	$20.19 - $84.93 $5 Million - $21.1 Million	247,880 Added 75.4%	576,617 $49 Million
Q3 2020 Nov 16, 2020	SELL	$22.99 - $36.34 $337,125 - $532,889	-14,664 Reduced 4.27%	328,737 $7.76 Million
Q2 2020 Aug 14, 2020	SELL	$29.88 - $56.74 $1.11 Million - $2.1 Million	-37,078 Reduced 9.75%	343,401 $11.5 Million
Q1 2020 May 15, 2020	BUY	$33.0 - $54.5 $63,327 - $104,585	1,919 Added 0.51%	380,479 $15.3 Million
Q4 2019 Feb 14, 2020	BUY	$15.39 - $44.38 $5.06 Million - $14.6 Million	328,560 Added 657.12%	378,560 $15.6 Million
Q3 2018 Nov 14, 2018	BUY	$16.05 - $16.87 $802,500 - $843,500	50,000 New	50,000 $844,000

Others Institutions Holding ARVN

# of Institutions

230

Shares Held

68.4M

Call Options Held

226K

Put Options Held

285K

View Full List

About ARVINAS, INC.

Ticker ARVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,205,300
Market Cap $953M
Description
Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...

More about ARVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account

Arrow Mark Colorado Holdings LLC Arvinas, Inc. Transaction History